Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment
暂无分享,去创建一个
N. Verkaik | D. V. van Gent | M. de Jong | C. D. de Ridder | J. Nonnekens | W. V. van Weerden | E. de Blois | Stefan J. Roobol | D. Stuurman | E. Ruigrok | Debra C. Stuurman | C. de Ridder